Annie Neild

Consigliere Generale presso FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Health Technology

Consumer Services

Profilo

Annie Neild is currently the Executive VP & Head-Global Regulatory Affairs at NewAmsterdam Pharma Co. NV.
Previously, she worked as the Head-Regulatory Affairs at Corvidia Therapeutics, Inc. in 2020.
Ms. Neild holds a doctorate degree from Yale University.

Posizioni attive di Annie Neild

Società	Posizione	Inizio
FRAZIER LIFESCIENCES ACQUISITION CORPORATION	Consigliere Generale	01/03/2021

Tutte le posizioni attive di Annie Neild

Precedenti posizioni note di Annie Neild

Società	Posizione	Fine
Corvidia Therapeutics, Inc. Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.	Consigliere Generale	01/07/2020

Vedi nel dettaglio l'esperienza di Annie Neild

Formazione di Annie Neild

Yale University

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Annie Neild

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
FRAZIER LIFESCIENCES ACQUISITION CORPORATION	Health Technology

Aziende private	1
Corvidia Therapeutics, Inc. Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.	Health Technology